Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J HIRSH

Showing results (321-330 of 666) with videos related to

Pageof 67
Sort By:
Journal of the American College of Cardiology|May 23, 2015
Fibrotic atrial cardiomyopathy, atrial fibrillation, and thromboembolism: mechanistic links and clinical inferencesBenjamin J Hirsh, Robert S Copeland-Halperin, Jonathan L Halperin
Thrombosis Research|October 1, 1980
Preparation and partial characterization of human plasma depleted of antithrombin-III by heparin-sepharose affinity chromatographyH Hoogendoorn, A Cerskus, F Ofosu, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 14, 2001
Mechanism of action and pharmacology of unfractionated heparinJ Hirsh, S S Anand, J L Halperin, et al.
Thrombosis and Haemostasis|September 1, 1993
The additive effect of low molecular weight heparins on thrombin inhibition by dermatan sulfateB Cosmi, G Agnelli, E Young, et al.
Archives of Internal Medicine|September 12, 1994
Diagnostic tests for deep vein thrombosis. Clinical usefulness depends on probability of diseaseH B Wheeler, J Hirsh, P Wells, et al.
The New England Journal of Medicine|April 5, 1979
Elevated platelet-associated IgG in the thrombocytopenia of septicemiaJ G Kelton, P B Neame, J Gauldie, et al.
Thrombosis and Haemostasis|March 1, 1994
Ex-vivo and in-vitro evidence that low molecular weight heparins exhibit less binding to plasma proteins than unfractionated heparinE Young, P Wells, S Holloway, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1995
Very low-dose warfarin prophylaxis to prevent thromboembolism in women with metastatic breast cancer receiving chemotherapy: an economic evaluationR Rajan, A Gafni, M Levine, et al.
Annals of the New York Academy of Sciences|January 1, 1987
Evolution of thrombosisJ Hirsh, M R Buchanan, F A Ofosu, et al.
Mineral and Electrolyte Metabolism|January 1, 1990
Effect of verapamil on intestinal absorption of calcium in the ratU Gafter, H Barak, J Hirsh, et al.
Pageof 67

Showing results (321-330 of 666) with videos related to

Sort By:
Pageof 67
Journal of the American College of Cardiology|May 23, 2015
Fibrotic atrial cardiomyopathy, atrial fibrillation, and thromboembolism: mechanistic links and clinical inferencesBenjamin J Hirsh, Robert S Copeland-Halperin, Jonathan L Halperin
Thrombosis Research|October 1, 1980
Preparation and partial characterization of human plasma depleted of antithrombin-III by heparin-sepharose affinity chromatographyH Hoogendoorn, A Cerskus, F Ofosu, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 14, 2001
Mechanism of action and pharmacology of unfractionated heparinJ Hirsh, S S Anand, J L Halperin, et al.
Thrombosis and Haemostasis|September 1, 1993
The additive effect of low molecular weight heparins on thrombin inhibition by dermatan sulfateB Cosmi, G Agnelli, E Young, et al.
Archives of Internal Medicine|September 12, 1994
Diagnostic tests for deep vein thrombosis. Clinical usefulness depends on probability of diseaseH B Wheeler, J Hirsh, P Wells, et al.
The New England Journal of Medicine|April 5, 1979
Elevated platelet-associated IgG in the thrombocytopenia of septicemiaJ G Kelton, P B Neame, J Gauldie, et al.
Thrombosis and Haemostasis|March 1, 1994
Ex-vivo and in-vitro evidence that low molecular weight heparins exhibit less binding to plasma proteins than unfractionated heparinE Young, P Wells, S Holloway, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1995
Very low-dose warfarin prophylaxis to prevent thromboembolism in women with metastatic breast cancer receiving chemotherapy: an economic evaluationR Rajan, A Gafni, M Levine, et al.
Annals of the New York Academy of Sciences|January 1, 1987
Evolution of thrombosisJ Hirsh, M R Buchanan, F A Ofosu, et al.
Mineral and Electrolyte Metabolism|January 1, 1990
Effect of verapamil on intestinal absorption of calcium in the ratU Gafter, H Barak, J Hirsh, et al.
Pageof 67